The invention discloses micro RNA for accelerating tissue-engineered bone vascularization and application thereof and belongs to the technical field of gene engineering. The micro RNA...
The invention relates to vesicles which include epidermal growth factor (EGF), a cationic surface-active agent, and cholesterol or the derivatives thereof. The invention also discloses...
The invention discloses a high-strength degradable cartilage tissue engineering scaffold and a preparation method thereof. The high-strength degradable cartilage tissue engineering scaffold is formed by...
The invention provides a three-dimensional complex cell aggregate model as well as a preparation method and application thereof. According to the model, a natural or...
The invention relates to an anatomical composite three-dimensional scaffold tissue engineering cartilage and a preparation method thereof. According to the anatomical composite three-dimensional scaffold tissue...
The present invention relates to biofunctional polymeric substrates product comprising immobilized antibodies that selective bind to antigens namely autologous growth factors and an inflammatory molecule,...
The invention belongs to the field of histocytology and tissue engineering and discloses a tissue-engineered epidermis with hypodermal cells and a preparation method thereof. The...
The invention relates to a tissue engineering scaffold material based on vinyl-sulfydryl crosslinking and a preparation method thereof. The vinyl-sulfydryl crosslinking reaction has hypoxic sensitivity...
The invention relates to a method for obtaining tissue engineering cartilage through directionally inducing bone-marrow mesenchymal stem cells (BMSCs). At present, a large amount of...
The invention discloses a culture method for the composition of a periosteal biological scaffold and allogenic seed cells. The culture method comprises the following steps:...
The invention relates to a cobra venom's nerve growth factor-induced chondrogenic differentiation method of mesenchymal stem cells. The method comprises the following steps: NGF is...
The invention relates to vesicles which include epidermal growth factor (EGF), a cationic surface-active agent, and cholesterol or the derivatives thereof. The invention also discloses...
The invention discloses a multi-channel nerve repair conduit with a tissue induced function and a mold; chitosan-coated salidroside microspheres and composite type salidroside slow-release microspheres...
The invention discloses a PLGA-chitosan one-way slow-release membrane and a preparation method and use thereof. The preparation method comprises the following steps: (1) preparing a...
The invention relates to a high strength multistage micro-nano structural silicon-based bone repair scaffold material and a preparation method and application thereof, the multistage structural...
This application provides a microsphere suitable for tissue engineering that comprises connective tissue growth factor (CTGF). Also provided is a matrix, material or scaffold suitable...
The invention relates to a medical material of tissue engineering and especially relates to a tissue engineering neural restoration material constructed by autologous plasma. The...
The invention relates to a construction method of a controlled-release TrkC receptor ligand-NT-3 (neurotrophin-3) gelatin sponge cylinder bracket for repairing the spinal cord injury, particularly...
The invention relates to vesicles comprising Epidermal Growth Factor (EGF), a cationic surfactant and cholesterol or derivatives thereof. The invention also discloses a procedure for...
The invention relates to vesicles which include epidermal growth factor (EGF), a cationic surface-active agent, and cholesterol or the derivatives thereof. The invention also discloses...
